Martina Gahlemann

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

Diane Lefaudeux, Bertrand De Meulder, Matthew J. Loza et al. · Journal of Allergy and Clinical Immunology · 2016 · 292 citations · Full text

Life Sciences, Bioinformatics, Biomedical Informatics +14

Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial

Huib A.M. Kerstjens, Bernd Disse, W Schröder-Babo et al. · Journal of Allergy and Clinical Immunology · 2011 · 277 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +11

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

Kristin B. Highland, Oliver Distler, Masataka Kuwana et al. · The Lancet Respiratory Medicine · 2021 · 212 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation

Zala Jevnikar, Jörgen Östling, Elisabeth Ax et al. · Journal of Allergy and Clinical Immunology · 2018 · 193 citations · Full text

Life Sciences, Immunology, Cellular Immunology +13